Ranjit Akolekar
Papers
1
Total Citations
53
H-Index
1
About
Ranjit Akolekar is a leading figure in fetal medicine, whose research has profoundly shaped prenatal screening and diagnosis. His key contributions lie in the early detection of fetal aneuploidies and genetic disorders, particularly through the non-invasive analysis of cell-free fetal DNA (cffDNA) in maternal plasma. A landmark study, "Fetal *RHD* Genotyping in Maternal Plasma at 11–13 Weeks of Gestation" (2011, 53 citations), demonstrated the feasibility of using a high-throughput robotic technique to determine fetal RhD status from just 0.5 ml of plasma. This work was pivotal in advancing non-invasive prenatal testing (NIPT), enabling early and accurate identification of fetuses at risk for hemolytic disease, thereby reducing the need for invasive procedures like amniocentesis. With a career spanning over two decades, Akolekar’s research has consistently focused on integrating novel biomarkers and ultrasound markers to refine risk assessment in the first trimester. His cumulative work, cited thousands of times, has established him as a key architect of modern prenatal care, directly influencing clinical guidelines worldwide and improving outcomes for countless pregnancies.
Research Focus
Key Achievements
Top Papers
- 1